학술논문

Evaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors
Document Type
Article
Source
In: Oncologist. (Oncologist, October 2023, 28(10):E950-E959)
Subject
Language
English
ISSN
1549490X
10837159